Search Results for "tseng"
News & Announcements
Dr. Celestin was inducted into the LSU Health New Orleans Delta Omega Honorary Society in Public Health, Alpha Psi Chapter.
Dr. Tung-Sung Tseng received the 2022 Dr. Allen A. Copping Award for Excellence in Teaching at the School of Public Health, LSU Health New Orleans
Statistics about youth tobacco use from the most recent National Youth Tobacco Survey
Statistics about adult tobacco use from the most recent National Health Interview Survey
Submit Comments on Tobacco Products
Make your voice heard and be part of the ongoing effort to improve public health in the United States.
Thomas, S.M., Horswell, R., Celestin, M.D., Dellinger, A.B., Kaiser, M., Butler, M. (2010). Awareness and Implementation of the 2000 US Public Health Service Tobacco Dependence Treatment Guideline in a Public Hospital System. Population Health Management; 14(2): 79-85.
Moody-Thomas, S., Celestin, M., Horswell, R. (2013). Use of systems change and health information technology to integrate comprehensive tobacco cessation services in a statewide system for delivery of healthcare. Open Journal of Preventive Medicine; 3: 75-83.
Moody-Thomas, S., Celestin, M.D., Tseng, T.S., Horswell, R. (2013). Patient tobacco use, quit attempts, and perceptions of healthcare provider practices in a safety-net healthcare system. Ochsner Journal; (13)3: 367-74.
Purcell, E.P., Mitchell, C., Celestin, M.D., Evans, K.R., Haynes, V., McFall, A., Troyer, L., Sanchez, M.A. (2013). Research to Reality (R2R) Mentorship Program: Building Partnership, Capacity, and Evidence. Health Promotion Practice; 14(3): 321-327.
Tseng, T.S., Moody-Thomas, S., Horswell, R., Yi, Y., Celestin, M.D., Jones, K.D. (2014). Using a health informatics system to assess effect of a federal cigarette tax increase on readiness to quit among low-income smokers, Louisiana, 2009. Prev Chronic Dis;11: E52.
Celestin, M.D., Hart, A., Moody-Thomas, S. (2014). Partnering with Health Care Systems to Assess Tobacco Treatment Practices and Beliefs among Clinicians: Evaluating the Process. Preventing Chronic Disease; 11:130277.
Moody-Thomas, S., Nasuti, L., Yi, Y., Celestin, M.D., Horswell, R., Land, T.G. (2015). Effect of systems change and use of electronic health records on quit rates among tobacco users in a public hospital system. Am J Public Health, Vol. 105, No. S2, pp. e1-e7.
Celestin, M.D., Tseng, T.S., Moody-Thomas, S., Yi, Y., Jones-Winn, K., Hayes, C., Guillory, D. (2016). Effectiveness of group behavioral counseling on long-term quit rates in primary health care. Transl Cancer Res;5(Suppl 5): S972S982.
Hayes-Watson, C., Nuss, H., Tseng, T.S., Parada, N., Yu, Q., Celestin, M.D., Guillory, D., Jones-Winn, K., Moody-Thomas, S. (2017). Self-management practices of smokers with asthma and/or chronic obstructive pulmonary disease: A cross sectional survey. COPD Research and Practice; 3(3): 1-7. https://doi.org/10.1186/s40749-017-0022-0.
Celestin, M.D., Ferguson, T., Ledford, E.C., Tseng, T.S., Carton, T.W., Moody-Thomas, S. (2018). Differences in Treating Tobacco Use across National, State, and Public Hospital System Surveys. Prev Chronic Dis;15:170575
Hayes-Watson, C., Nuss, H., Celestin, M.D., Tseng, T.S., Parada, N., Yu, Q., Moody-Thomas, S. (2018). Health beliefs associated with poor disease self-management in smokers with asthma and/or COPD. J. Asthma; 1–8.
Kao, Y.H., Celestin, M.D., Yu, Q., Moody-Thomas, S., Jones Winn, K., Tseng, T.S. (2019). Racial and Income Disparities in Health-Related Quality of Life among Smokers with a Quit Attempt in Louisiana. Medicina (Kaunas); 55(2).
Tseng, T.S., Gross, T., Celestin, M.D., Dang, W., Young, L., Kao, Y.H., Li, M., Smith, D.L., Bok, L.R., Fuloria, J., Moody-Thomas, S. (2019). Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans—a mixed method study. Transl Cancer Res;8(Suppl 4):S431-S442. https://doi: 10.21037/tcr.2019.04.18.
Kao, Y., Celestin, M.D., Walker, C.D., Yu, Q., Couk, J., Moody-Thomas, S., et al. (2019). Smoking Relapse and Type 2 Diabetes Mellitus–Related Emergency Department Visits Among Senior Patients with Diabetes. Prev Chronic Dis; 16:190027.
Luo T, Li MS, Williams D, Phillippi S, Yu Q, Kantrow S, Kao YH, Celestin M, Lin WT, Tseng TS. (2021). Using social media for smoking cessation interventions: a systematic review. Perspect Public Health. Jan;141(1):50-63. Epub 2020 Feb 20. PMID: 32077368
Kao YH, Tseng TS, Celestin MD, Hart J, Young L, Li M, Bok LR, Smith DL, Fuloria J, Moody-Thomas S, Trapido EJ. (2021) Association Between the 5As and Stage of Change Among African American Smokers Eligible for Low-Dose Computed Tomography Screening. Prev Chronic Dis. 2021 Jul 15;18:E71. doi: 10.5888/pcd18.210073. PMID: 34264811; PMCID: PMC8300539.
Tseng TS, Celestin MD Jr, Yu Q, Li M, Luo T, Moody-Thomas S. Use of Geographic Information System Technology to Evaluate Health Disparities in Smoking Cessation Class Accessibility for Patients in Louisiana Public Hospitals. Front Public Health. 2021 Aug 12;9:712635. doi: 10.3389/fpubh.2021.712635. PMID: 34476230; PMCID: PMC8406529.
Celestin Jr MD, Gee RE. The epidemic during the pandemic: assessing the Federal Drug Administration’s efforts to curb youth smoking after passage of HR2339 by Congress. Am J Public Health. 2022;112(7):1005–1006. https://doi.org/10.2105/AJPH.2022.306901.
The studies listed on this site have been approved by the LSU Health Sciences Center New Orleans Human Subjects Research Protection Program (HRPP) and the Institutional Review Board (IRB), which works to ensure and protect the rights and welfare of individuals participating in research.
Why should you participate? Participating in research allows you to help yourself as well as humanity. You can receive help and support to quit tobacco and help us learn how to help others in your community.
Eligibility: For questions about a specific study and eligibility requirements, please call or email Ty-Runet Bryant at 504-568-5705 or email@example.com
Title: Quit Intervention for Pregnant/Postpartum Smokers
Principal Investigator: Michael Celestin, Jr., Ph.D.
Purpose: Quips is a research study focused on helping WIC participants 18 and older who are pregnant or up to 6 months postpartum and current smokers quit.
- Complete 2-6 short phone calls where you will answer questions and listen to messages
- You will receive a gift card
- 18 years of age or older
- Smoke regular or electronic cigarettes, vaping devices currently or in the past 2 years
- Pregnant or had a baby up to 6 months ago
- Have a smartphone or cell phone
Open for enrollment in the Fall of 2022!
Title: Using FeNO Test Monitoring as a Health Risk Communication Tool to Promote Smoking Cessation for Smokers Diagnosed with Asthma and/or COPD
Principal Investigator: Michael Celestin, Jr., Ph.D.
Purpose: FeNO is a research study using biomedical feedback to promote quitting among current smokers diagnosed with Asthma and/or Chronic Obstructive Pulmonary Disease (A/COPD)
- Participate in phone interviews and surveys and complete an intervention
- You will receive a loadable ClinCard for each interview completed and for completing the cessation intervention
- 18 years of age or older
- Current diagnosis of Asthma and/or COPD
- Ability to complete FeNO test
- Willingness to adhere to the study intervention regimen
Open for enrollment in the Fall of 2022!
Title: Surveying Patterns of Tobacco Use among Patients and Knowledge, Attitudes, and Behavior of Clinicians in Louisiana’s Hospitals
Principal Investigator: Michael Celestin, Jr., Ph.D.
Purpose: To assess patient tobacco use, perceptions of provider tobacco treatment, and quit attempts within Louisiana’s safety-net public hospital system and compare them to baseline data; nurse and physician and nurse knowledge, attitude and behavior with regard to smoking cessation assistance and counseling.
Title: Assessing Awareness and Implementation of the US PHS Tobacco Use Treatment Guideline among FQHCs
Principal Investigator: Michael Celestin, Jr. ,Ph.D.
Purpose: Administer a baseline assessment to assess awareness and implementation of the US Public Health Service clinical practice guideline for tobacco use treatment among Federally Qualified Heath care Centers in Louisiana in preparation for integrating comprehensive tobacco treatment services for their patients.
Title: Assessing the Effectiveness of Clinic-Based Tobacco Control Programs
Principal Investigator: Michael Celestin, Jr., Ph.D.
Purpose: Assess the effectiveness and cost-effectiveness of clinic-based smoking cessation interventions using retrospective data from electronic health records for multiple provider systems.
Title: Disparities in the Utilization of Evidence-Based Tobacco Cessation Services in a Public Hospital System
Principal Investigator: Michael Celestin, Jr. Ph.D.
Purpose: The purpose of the study is to develop, within the Louisiana public hospital system, a profile of adult tobacco users who chose group behavioral counseling as a method for quitting.
Completed Research Studies
Title: Using Low-dose computed tomography (LDCT) lung cancer screening to increase smoking cessation among African-Americans
Principal Investigator: Tung-Sung Tseng, DrPH
Purpose: A first step to explore and address the smoking cessation needs of at-risk African American smokers undergoing lung cancer screening using the Theory of Planned Behavior to expand our understanding of the ideal teachable moment and content (barriers and facilitators) for a smoking cessation intervention in a lung cancer screening context.
Title: Improving Tobacco Cessation Services for HIV Patients
Principal Investigator: Sarah Moody-Thomas, Ph.D.
Purpose: The purpose of this study is to obtain information about effective methods of incorporating tobacco cessation services through the Tobacco Control Initiative (TCI) that are designed specifically for HIV positive smokers.
Our Study Team
|Michael D. Celestin, Jr., Ph.D., CHES, NCTTS
Director, Louisiana Tobacco Control Initiative
Dr. Michael Celestin is an Assistant Professor of Behavioral and Community Health Sciences at the LSU Health New Orleans School of Public Health. He is also the Director of the Louisiana Tobacco Control Initiative. His research expertise is in the dissemination and implementation of evidence-based health systems change policies and interventions to ensure cessation treatment for low socio-economic groups most likely to use tobacco and suffer from tobacco-related disabilities, diseases, and deaths. Dr. Celestin recently received a Roadmap Scholars Award from the Louisiana Clinical and Translational Science Center (LA CaTS). His project is entitled “Promoting Implementation of Interventions to Improve Tobacco Cessation in Healthcare (PITCH) for Rural Populations.”
|Tyra T. Gross, Ph.D., MPH
Dr. Tyra Toston Gross is an Associate Professor of Public Health at Xavier University of Louisiana, where she has worked as a public health instructor, researcher, and mentor since August 2015. Before joining Xavier, she completed a postdoctoral fellowship in reproductive women’s health at the University of Texas Medical Branch. Her research expertise is in maternal & child health disparities. Given her interest in maternal & child health, the majority of Dr. Gross’ research has focused on the health of reproductive-age women. Her current research projects explore the health of Black postpartum women in Louisiana, infant & young child feeding during emergencies, and smoking cessation needs for low-income pregnant women.
|Tung-Sung Tseng, DrPH, MS
Dr. Tung-Sung Tseng is an Associate Professor with tenure and the Charles L. Brown, MD, Endowed Professor of Health Promotion and Disease Prevention in Behavioral and Community Health Sciences at the School of Public Health at LSU Health New Orleans. His research interests include tobacco control, childhood obesity, gene-environment interaction, risk behavioral patterns, community-based participatory research (CBPR), health promotion interventions and evaluations, health disparities, and cancer prevention among ethnic minorities and underserved populations. He serves as a lead evaluator of the Louisiana Tobacco Control Initiative.
|Claire Hayes Watson, Ph.D., MPH
|Qingzhao Yu, Ph.D.
Dr. Qingzhao Yu is a Professor of Biostatistics at LSU Health New Orleans School of Public Health. Dr. Yu is interested in developing statistical methods for public health, health care, and clinical and lab research. She has published over a hundred peer-reviewed papers on statistical methodology development and collaborations. Dr. Yu’s research interests include Bayesian Modeling, Bayesian Clinical Trial, Causal Effect Analysis, Computational Method, Health Disparities, Machine Learning and Data Mining, Mediation Analysis, Spatial Analysis, and Survey Research. She serves as the Lead Biostatistician of the Louisiana Tobacco Control Initiative.
|Ty-Runet Bryant, MPH
Research Program Manager
Ty-Runet Bryant serves as the Program Manager for Research for the Louisiana Tobacco Control Initiative at Louisiana State University Health Sciences Center School of Public Health in New Orleans, LA. She holds a B.S. in Chemistry from Loyola University New Orleans and an MPH from Tulane University School of Public Health and Tropical Medicine. She has over 15 years of experience implementing, monitoring, and evaluating community-based health initiatives, leading community outreach efforts, and coordinating the submission of program and research grant proposals.
According to Dr. Tung-Sung Tseng, associate professor at Louisiana State University Health Sciences Center (LSUHSC) School of Public Health, the purpose of this study is to investigate knowledge, attitudes, and smoking cessation needs for African Americans who receive low dose computed tomography (LDCT) in an effort to reduce the health burden of lung cancer.
The research team gathered data using a self-administered questionnaire and structured in-depth interview. Descriptive statistics were used to provide summary information on knowledge, attitude and smoking behaviors, and thematic analysis was used to analyze interview data. The sample size for both the quantitative and qualitative approach was fifteen. The results showed that 73 percent of participants were male, the mean age was 61.8 years old, and 66.7 percent of participants had an income less than $20,000. Eighty percent had an education level of high school or below and 73.3 percent were overweight or obese. Smoking history was long (mean years =39 SD =14.9), but the number of cigarettes smoked per day was low (mean =9.2 SD =7.3), and 64 percent of the patients had a low nicotine dependence. Assessment of knowledge and attitudes towards LDCT revealed that participants had a moderate knowledge score (mean =4.3 SD =2.6), and most had a positive attitude. All participants planned to quit smoking, with 73 percent planning to quit within the next 6 months. The team concluded that African Americans who receive LDCT lung cancer screening in this study have a moderate/lower knowledge score and positive attitude towards LDCT. Understanding the factors associated with smoking cessation among at-risk African American smokers will help reduce disparities in lung cancer burden and is important to improve health for medically underserved minority populations.
An elevated neutrophil to lymphocyte ratio (NLR) has been proven as a vital predictor of progression and mortality for prostate cancer. Smoking is a risk factor for increasing NLR. Drs. Tung-Sung Tseng, Yu-Hsiang Kao along with a team of researchers from the Louisiana State University Health Sciences Center (LSUHSC) School of Public Health examined the effect of smoking on NLR among prostate cancer survivors.
A total of 354 men adults aged ≥20 years old with prostate cancer were analyzed using the National Health and Nutrition Examination Survey (NHANES) 2005–2016 data. The primary outcome was NLR, which was classified into two levels: high (≥3) and low (<3). Sampling weighted logistic regressions were used for evaluating associations between smoking and NLR among prostate cancer survivors. The team found that 33.2 percent (n=111) of prostate cancer survivors had an elevated NLR. Prostate cancer survivors with a high NLR were older (mean 73.5 years old), non-Hispanic white (38.5 percent), higher income (poverty income ratio >1, 34.7 percent), and longer years after diagnosis (8.8 years) compared to counterparts with a low NLR.
Smoking status did not have a significant impact on NLR. The interaction test between race and smoking status was significant (P=0.04). Non-Hispanic black who were current smokers were observed more likely to have high NLR than never smokers [adjusted odds ratio (OR) =3.69, 95 percent CI: 1.36–9.99]. However, the effect of smoking on NLR was not observed among either non-Hispanic whites or other races. In conclusion: Non-Hispanic black prostate cancer survivors who were a current smoker were more likely to have NLR ≥3 compared to non-smokers. Smoking cessation could benefit these patients in prostate cancer management and reduce the risk of progression and mortality.
Continuity of care (COC) is a core element of primary care, which has been associated with improved health outcomes. Hospitalizations for ambulatory care sensitive conditions (ACSCs) are potentially preventable if these conditions are managed well in the primary care setting. The team of researchers, including from Louisiana State University Health Sciences Center School of Public Health, Dr. Kao and Dr. Tung-Sung Tseng’s aim, was to conduct a systematic review of literature on the association between COC and hospitalizations for ACSCs. They used the Systematic literature review, a method which all published literature was searched for in PubMed and MEDLINE using PRISMA guidelines for collecting empirical studies. Studies published in English between 2008 and 2017 that measured the association between COC and at least one measure of ACSC hospitalizations were included in this review
Their results, a total of 15 studies met the inclusion criteria and applied claims data to examine the association between COC and ACSC hospitalizations. Most studies (93.3 percent) demonstrated a statistically significant association of higher COC in the outpatient setting with reduced likelihood of hospitalization for either all ACSCs or a specific ACSC. A strong association was observed among studies focusing on patients with a specific ACSC. The team concluded that this systematic review identified an increased COC in outpatient care is associated with fewer hospitalizations for ACSCs. Increasing COC is favorable for patients who are managing a specific ACSC.
February 13, 2019 – New Orleans, LA
In the recent study, “Racial and Income Disparities in Health-Related Quality of Life among Smokers with a Quit Attempt in Louisiana,” published in Medicina 2019, smoking was found to be associated with a lower health-related quality of life (HRQOL). However, there is little information about the association between HRQOL in relation to race, income, and smoking status. The present study aimed to assess the association between HRQOL and smoking status for those of different races and income levels.
Authorship and contribution to this research and publication from the LSU Health Sciences Center School of Public Health includes current Fellow Yu-Hsiang Kao, Dr. Tung-Sung Tseng, Mr. Michael D. Celestin, Jr. , Dr. Sarah Moody-Thomas from Behavioral & Community Health. Also, contributing to this research is Mrs. Krysten Jones-Winn from the Tobacco Control Initiative Program and Dr. Qingzhao Yu from Biostatics.
This study’s conclusions state that racial and income disparities were evident with regards to HRQOL, with lower-income black or African Americans who were current smokers with a quit attempt having a lower HRQOL. Intervention programs for smoking cessation should target lower-income black or African American smokers who have a prior quit attempt and provide effective cessation services to help them quit smoking and improve their HRQOL.
The full publication can be read here.
Faculty and researchers at the LSU School of Medicine (Drs. Stephen Kantrow and Sarah Jolley), Louisiana State University Health Sciences Center School of Public Health (Ms. Xinnan Wang, Dr. Tung-Sung Tseng, Dr. Dodie Arnold, Dr. Claudia Leonardi, Dr. Richard Scribner, Dr. Edward Trapido, Dr. Hui-Yi Lin), Ochsner Health System (Eboni Price Haywood) and the Louisiana Public Health Institute (Dr. Lisanne Brown) used emergency department (ED) data to estimate the prevalence of smoking in young adults. Most state or national surveys of smoking are limited in size- especially when looking at county level data, and phone based surveys have had decreasing responses. School based surveys are helpful, but limited by age.
The researchers used data from electronic health records (EHRs) for five EDs within U.S. Census-defined metropolitan New Orleans (New Orleans–Metairie, LA) for persons 18-24 years old. (15 percent of young adults are reported to have used EDs in the past year). Smoking status was available for 55,777 persons (91 percent of the total Emergency Departments); 61 percent were women, 55 percent were black, 35 percent were white, and 8 percent were Hispanic. One third of patients were uninsured. Most smokers used cigarettes (95 percent ). Prevalence of current smoking was 21.7 percent for women and 42.5 percent for men. Smoking prevalence was highest for substance use disorder (58 percent ), psychiatric illness (41 percent ) and alcohol use (39 percent ), and lowest for pregnancy (13.5 percent ). In multivariable analyses, male gender, white race, lack of health insurance, alcohol use, and illicit drug use were independently associated with smoking. Smoking risk among alcohol and drug users varied by gender, race, and/or age.
The BRFSS estimated 29 percent prevalence during the same time, and had data on 597 subjects aged 18–30 years. Although ED data are likely to overestimate tobacco use, the large sample size is useful- especially for stratum-specific estimates- particularly in a demographically diverse population. Dr. Stephen Kantrow, the lead investigator, stated ”this approach provides smoking data for a large sample of young adults in one metropolitan area, and may support longitudinal studies of smoking in high and low risk populations.